LivaNova wins CE Mark for PureFlex arterial cannulae

LivaNova (NSDQ:LIVN) said yesterday it won CE Mark approval in the European Union for its PureFlex line of adult arterial cannulae.

The newly cleared PureFlex cannulae are designed with curved and straight tip options and feature phthalate-free flexible tubing and a wire-reinforcement spring, the London-based company said.

“Our decades-long commitment to excellence in cannulation continues with the addition of the new PureFlex cannulae to our robust portfolio. We call it ‘the cannulae that can. Now with CE Mark, we are eager to offer this high-quality line of cannulae to cardiac surgery teams and skilled surgeons, benefitting the full range of adult conventional cardiac surgery patients and delivering the best care possible,” LivaNova cardiac surgery biz GM Alistair Simpson said in a prepared statement.

Last month, LivaNova said it closed the $225 million buyout of ImThera Medical and its implantable sleep apnea treatment.

The post LivaNova wins CE Mark for PureFlex arterial cannulae appeared first on MassDevice.

from MassDevice http://ift.tt/2EcBIyX